eXCELL Biotherapeutic
  • About
  • Science and Technology
    • Science
    • Technology
  • Latest News
    • News
    • Media
  • Program
  • Publications
    • Journal Articles
    • Patents
  • Contact
eXCELL Biotherapeutic
選單
white and red plastic tools
19 11 月
2022 FDA INTERACT meeting

Nov.19. 2022 Announces Successful Completion of INTERACT, pre-IND Meeting with FDA

  • 2024-02-08
  • By author-avatar eXCELL
eXCELL Biotherapeutics Inc., a biopharmaceutical company advancing xenogeneic cellular therapeutics ...

閱讀更多

cell therapy
10 10 月
2022 FDA IND Initial

Oct.10. 2022 eXCELL, Inc., granted a pre-pre-Investigational IND for Regulatory Advice on CBER products INTERACT meeting with U.S. FDA

  • 2024-02-08
  • By author-avatar eXCELL
eXCELL, Inc., a leader in developing the next generation of xenogeneic cell immunotherapies for canc...

閱讀更多

關閉
搜尋文章
文章分類
  • 2022 FDA IND Initial (1)
  • 2022 FDA INTERACT meeting (1)
  • 2023 BIO International Convention (1)
  • 2023 Japan Patent Issued (1)
  • 2023 New Zealand Collaboration (1)
  • 2023 New Zealand NZeno Supports (1)
  • 2023 Received SBIR Award (1)
  • 2024 Taiwan Patent Issued (1)
  • 2024 Top 15 Start Up (1)
  • 2024 US Patent Issued (1)
  • 2025 Startup Growth Accelerator (1)
  • Latest Progress (3)
  • The Regenerative Medicine Act and Regenerative Pharmaceuticals act Approval in Taiwan (1)
  • 立法院三讀通過「再生醫療法」開啟再生醫療新里程 (1)
關閉
輸入您想搜尋的商品關鍵字，開始進行搜尋吧！
Contact Us
聯絡地址：
No. 31, Beiping 3rd St., North Dist., Taichung City 404 , Taiwan (R.O.C.)
電子信箱：
[email protected]
聯絡電話：
+886-4-23212960

©2026 Copyrights eXCELL Biotherapeutics Inc. All Rights Reserved | 網站系統建置 By SGI

  • About
  • Science and Technology
    • Science
    • Technology
  • Latest News
    • News
    • Media
  • Program
  • Publications
    • Journal Articles
    • Patents
  • Contact
更多 Scroll To Top